Last reviewed · How we verify
Radix codonopsitis
At a glance
| Generic name | Radix codonopsitis |
|---|---|
| Also known as | One of active ingredients in TCM group |
| Sponsor | Macrohard Institute of Health |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pinaverium and Herbs for Irritable Bowel Syndrome Treatment: an Onset and Offset Study (PHIBEST) (NA)
- A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel Syndrome (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Radix codonopsitis CI brief — competitive landscape report
- Radix codonopsitis updates RSS · CI watch RSS
- Macrohard Institute of Health portfolio CI